Skip to main content

Bacteremia caused by Desulfovibrio desulfuricans with the intestinal tract as the portal of entry: two case reports and a literature review

Abstract

Background

Desulfovibrio desulfuricans (D. desulfuricans), a commensal anaerobic gram-negative rod endemic to the soil environment and human gastrointestinal tract, rarely causes bloodstream infections. We report two rare cases of bacteremia caused by D. desulfuricans in which the intestinal tract was the portal of entry. In addition, we summarize findings on D. desulfuricans.

Case presentation

Case 1: A 51-year-old man presented to the emergency department with the chief complaints of fever and right lower abdominal pain. He was admitted to the hospital with ascending colonic diverticulitis and received empirical antibacterial therapy with piperacillin/tazobactam. Blood culture revealed D. desulfuricans. The patient was discharged after 2 weeks of antimicrobial therapy. Case 2: A 95-year-old woman presented to our hospital with a chief complaint of fever. Owing to an elevated inflammatory response and pyuria, the patient was diagnosed with pyelonephritis and treated with ceftriaxone. Klebsiella pneumoniae was detected in her urine culture, while D. desulfuricans was detected in her blood culture. The patient was then treated with ampicillin/sulbactam for 14 days. The fecal occult blood test result was positive, suggesting a colonic mucosal lesion, such as a malignant tumor, may have been the portal of entry for D. desulfuricans bacteremia. Previous literature reviews indicate that D. desulfuricans bacteremia often results from liver or renal abscesses, intestinal lesions, among others, serving as the portal of entry. Although no specific underlying disease has been reported, it is more common in the older population. We encountered two cases of D. desulfuricans bacteremia and combined them with 15 cases from previous studies to explore the characteristics of the disease. The proportion of patients aged \(\:\ge\:\)60 years was 73.7%; overall, 73.7% had gastrointestinal complications, and 63.2% had abdominal symptoms at the time of presentation.

Conclusions

We encountered two rare cases of D. desulfurican bacteremia. This type of bacteremia is more common in elderly people over 60 years of age and is often associated with hepatobiliary and gastrointestinal diseases.

Peer Review reports

Background

Desulfovibrio is a genus of commensal anaerobic Gram-negative rods that are ubiquitous to the soil environment and human gastrointestinal tract. These bacteria have a characteristic curved morphology and motility, requiring more time for development than usual [1, 2].

The genus Desulfovibrio currently includes more than 60 species, of which six species, Desulfuricans, Desulfuricans fairfieldensis, Desulfuri vulgaris, Desulfuri piger, Desulfuri legallii, and Desulfuri intestinalis are known to be pathogenic to humans [3]. D. desulfuricans produces hydrogen sulfide, which has a characteristic sulfur-like odor. The first human infection, a bloodstream infection associated with liver abscesses, was reported by Tee et al. in 1996 [4]. Although the report by Porschen et al. in 1977 was considered the first [5], it is highly likely that it was caused by D. fairfieldensis and not D. desulfuricans based on the characteristics of the bacteriological examination [6]. A bloodstream infection by D. desulfuricans is often caused by intra-abdominal abscesses such as liver abscesses or intestinal lesions acting as a portal of entry [7, 8].

However, there are few reports of infections caused by D. desulfuricans, especially those involving the bloodstream [1, 4, 7, 8]. Here, we report two rare cases of bacteremia caused by D. desulfuricans entering the intestinal tract. We also summarize the previous literature on D. desulfuricans bacteremia.

Case presentation

Case 1

A 51-year-old man with independent activities of daily living was admitted to our hospital with the chief complaints of fever and right lower abdominal pain. He had a history of diverticulitis at the age of 30 years. He was taking amlodipine 5 mg/day for hypertension.

The day before his visit, he developed severe right lower abdominal pain after lunch and was treated with 60 mg loxoprofen. On the evening of the same day, he developed a fever of 38.6 ℃. Because his lower abdominal pain did not improve on the day of his visit, he visited the emergency room of our hospital. At admission, the patient’s vital signs were as follows: clear consciousness, a respiratory rate of 16 breaths/min, a temperature of 38.2 °C, a pulse of 105 beats/min, a blood pressure of 179/105 mmHg, and a peripheral oxygen saturation (SpO2) of 99% (in room air). Physical examination of the patient revealed no increase or decrease in intestinal peristalsis. Tenderness and tapping pain were observed from the right side of the umbilicus to the right lower abdomen. Recoil pain was noted as a symptom of peritoneal irritation; however, there was no evidence of muscular defense or Murphy’s sign.

The patient’s white blood cell count was 16,700/µL, and his C-reactive protein (CRP) level was 0.21 mg/dL. No abnormalities on urinalysis were found. A non-contrast computed tomography (CT) scan of the abdomen showed multiple highly absorptive diverticula in the ascending colon, some with free air (Fig. 1).

Fig. 1
figure 1

A non-contrast CT scan of the abdomen in case 1

CT shows multiple highly absorptive diverticula in the ascending colon, some with free air. CT, computed tomography

Based on these findings, the patient was diagnosed with ascending colonic diverticulitis. The patient was hospitalized and treated with intravenous piperacillin/tazobactam (4.5 g every 6 h). Subsequently, the CRP levels peaked at 13.4 mg/dL on day 4 of hospitalization and improved thereafter. His fever and abdominal pain gradually improved and resolved by day 6. On day 7 of hospitalization, two sets of blood cultures obtained on day 1 of hospitalization revealed the development of a spiral-shaped gram-negative rod. Bacterial identification by mass spectrometry identified the organism as D. desulfuricans. The patient was on adequate antimicrobial therapy, thus repeat blood cultures were not performed.

The patient was diagnosed with D. desulfuricans bacteremia associated with ascending colonic diverticulitis. The patient was discharged from hospital after 2 weeks of antimicrobial therapy. Three years have passed since the time of discharge without any recurrence.

Case 2

A 95-year-old woman presented to our hospital with a chief complaint of fever. She required nursing care for almost all her personal needs, including eating and toileting. She had previously been diagnosed with pancytopenia. However, since she declined further testing, a search for the cause of pancytopenia was not conducted. On the day of her visit, she presented to our emergency room because of cyanosis and a fever of 38.5 °C. Her medical history included pancytopenia of an unknown etiology. The patient also had aortic stenosis, bronchial asthma, hypertension, and dementia.

On arrival, her vital signs were clear, with a blood pressure was 112/77 mmHg, an irregular pulse of 64 beats/min, a temperature of 36.9℃, a respiratory rate of 12 breaths/min, and an SpO2 of 99% (in room air).

Physical examination revealed pallor of the eyelid and conjunctiva. Hemorrhagic spots were observed in the oral mucosa. Course crackles were auscultated in the right middle and lower lung fields, and tenderness was elicited by tapping over the right costovertebral angle. An ejection systolic murmur (Levine III/VI) was auscultated, with the strongest point in the second intercostal space of the right sternal border.

The patient’s white blood cell count was 6380/µL, and her CRP level was 8.1 mg/dL. Urinalysis showed a leukocyte count of > 100/high-power field. Simple chest radiography showed no evidence of pneumonia, and simple abdominal CT revealed no enlarged renal pelvis, ascites, or intestinal lesions. The patient was diagnosed with acute pyelonephritis based on the presence of fever and urinalysis findings. The patient was hospitalized and treated with antimicrobial therapy with ceftriaxone (1 g every 24 h). Her CRP level and fever gradually improved, with a peak CRP level observed on day 4 of hospitalization. Klebsiella pneumoniae was detected in her urine culture taken at initial visit. Furthermore, blood cultures on the third day of hospitalization revealed Gram-negative rods in two sets of blood culture, indicating bacteremia. Gram-negative rods were suspected to be Fusobacterium, and the antimicrobials were changed from ceftriaxone to ampicillin/sulbactam (3 g every 6 h). The Gram-negative rods that developed in both sets of blood cultures were subjected to mass spectrometry and identified as D. desulfuricans. At follow-up, two sets of repeat blood culture were negative because the patient was on antimicrobial therapy. Antimicrobial therapy was completed within 2 weeks, and the patient was discharged 35 days after rehabilitation. The final diagnosis was acute pyelonephritis due to K. pneumoniae and D. desulfuricans bacteremia.

K. pneumoniae was detected in the urine culture, whereas D. desulfuricans was detected in the blood culture. As they were different strains, a fecal occult blood test was performed; the test result was positive. Epigastroscopy and colonoscopy were proposed, although the patient refused to undergo these procedures. Two years have passed since discharge from the hospital, without any recurrence.

Table 1 shows the antimicrobial susceptibility results for the main antimicrobial agents in cases 1 and 2.

Table 1 Antimicrobial susceptibility testing of the D. desulfuricans isolate case 1. The susceptibility categories were based on the Clinical and Laboratory Standards Institute (CLSI) classification. ABPC, ampicillin; ABPC/SBT, ampicillin sulbactam; CLDM, clindamycin; CMZ, cefmetazole; CP, chloramphenicol; CPZ, cefoperazon; CTRX, ceftriaxone; CTX, cefotaxime; IPM/CS, imipenem cilastatin; MEPM, meropenem; MFLX, moxifloxacin; MNZ, metronidazole; PIPC, piperacillin; PIPC/TAZ, piperacillin/tazobactam; TC, achromycin; VCM, vamcomycin

Discussion

We present two rare cases of D. desulfuricans bacteremia, summarize previous reports of D. desulfuricans bacteremia using PubMed, and describe their clinical features.

A PubMed search for “Desulfovibrio desulfuricans” and “bacteremia” yielded 17 previously reported cases. Table 2 shows our two cases, in addition to those previously reported [1, 4, 7,8,9,10,11,12,13,14,15,16,17,18,19,20,21]. The median age of the patients was 69 (range, 18–95) years, 14 (73.7%) patients were aged \(\:\ge\:\)60 years, and the male-to-female ratio was 10:9. The outcome was death in two cases [15, 16], corresponding to a mortality rate of 10.5%. Twelve (63.2%) patients presented with fever [1, 4, 8, 9, 13, 16,17,18,19,20], and 12 (63.2%) had abdominal symptoms [1, 8,9,10, 13, 15, 16, 18,19,20,21].

Table 2 Reports of D. desulfuricans bacteremia

Four (21.1%) cases involved mixed infections with enterobacteria, including Eggerthella lenta, Christensenella minuta, and Escherichia coli. According to previous reports, older age (> 60 years) is a risk factor, and fragility of the gastrointestinal mucosa due to aging may be a contributing factor [7, 8]. Fourteen of the 19 (73.7%) patients had a gastrointestinal disease [1, 4, 9,10,11, 13,14,15, 17,18,19,20], while the remaining did not.

As in case 1, reports of bloodstream infections in patients aged < 60 years were rare, occurring in only 3 of 19 cases [9, 10].

In case 1, diverticulitis occurred, and the intestinal tract was considered the portal of entry. In case 2, there was no underlying lesion, but the different causative organisms of urinary tract infection and bacteremia, along with the positive result in fecal occult blood test, suggested the possibility of a malignant tumor or colonic mucosal lesion (e.g. inflammatory colonic lesion) as the entry point. However, a diagnosis was not made as the patient did not wish to undergo an endoscopic examination.

D. desulfuricans comprises two genotypes, Essex 6 and MB [2, 21]. The characteristics of their antimicrobial susceptibilities and the susceptibilities of cases 1 and 2 are shown in Table 2. Essex 6 isolates are less susceptible to β-lactams than MB isolates and are highly resistant to both piperacillin (PIPC) and cefoxitin (CFX) [2]. On the other hand, MB isolates are moderately susceptible to PIPC and CFX [2]. Based on a comparison of antimicrobial susceptibilities, the microbial agents detected in cases 1 and 2 were assumed to be D. desulfuricans MB. There is no established antimicrobial regimen for use against D. desulfuricans, and the optimal antimicrobial therapy remains unknown. In situations where the empirical use of broad-spectrum antimicrobial agents fails or when helminths are identified in anaerobic cultures, these organisms should be kept in mind and identified at the species level using mass spectrometry or 16 S rRNA gene sequence analysis. Strain identification may guide more optimal antimicrobial selection. Moreover, eight cases were reported from Japan, which may have been due to geographical factors, although the precise reason remains unclear. Further studies are anticipated in the future regarding this relationship.

Conclusion

We encountered two rare cases of D. desulfurican bacteremia and analyzed them along with 17 previous cases from the literature to characterize this condition. The proportion of patients aged ≥ 60 years was 73.7%; overall, 73.7% had gastrointestinal complications, and 63.2% had abdominal symptoms at the time of hospital admission.

Data availability

All data generated or analyzed during this study are included in this published article.

Abbreviations

CFX:

Cefoxitin

CRP:

C-reactive protein

CT:

Computed tomography

D. desulfuricans:

Desulfovibrio desulfuricans

PIPC:

Piperacillin

SpO2 :

Peripheral oxygen saturation

References

  1. Goldstein EJ, Citron DM, Peraino VA, Cross SA. Desulfovibrio desulfuricans bacteremia and review of human Desulfovibrio infections. J Clin Microbiol. 2003;41:2752–4.

    Article  PubMed  PubMed Central  Google Scholar 

  2. Nakao K, Tanaka K, Ichiishi S, Mikamo H, Shibata T, Watanabe K. Susceptibilities of 23 Desulfovibrio isolates from humans. Antimicrob Agents Chemother. 2009;53:5308–11.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Warren YA, Citron DM, Merriam CV, Goldstein EJ. Biochemical differentiation and comparison of Desulfovibrio species and other phenotypically similar genera. J Clin Microbiol. 2005;43:4041–5.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Tee W, Dyall-Smith M, Woods W, Eisen D. Probable new species of Desulfovibrio isolated from a pyogenic liver abscess. J Clin Microbiol. 1996;34:1760–4.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Porschen RK, Chan P. Anaerobic vibrio-like organisms cultured from blood: Desulfovibrio desulfuricans and Succinivibrio species. J Clin Microbiol. 1977;5:444–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Parte AC. LPSN-list of prokaryotic names with standing in nomenclature. Nucleic Acids Res. 2014;42:D613–6.

    Article  CAS  PubMed  Google Scholar 

  7. Hagiya H, Kimura K, Nishi I, Yamamoto N, Yoshida H, Akeda Y, et al. Desulfovibrio desulfuricans bacteremia: a case report and literature review. Anaerobe. 2018;49:112–5.

    Article  PubMed  Google Scholar 

  8. Nasreddine R, Argudin MA, Herpol M, Miendje Deyi VY, Dauby N. First case of Desulfovibrio desulfuricans bacteraemia successfully identified using MALDI-TOF MS. New Microbes New Infect. 2019;32:100614.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Lopez Alonso B, von Irigoyen A, Sáez Nieto JA, Rosel AB. First report of human infection by Christensenella minuta, a gram-negative, strickly anaerobic rod that inhabits the human intestine. Anaerobe. 2017;44:124–5.

    Article  Google Scholar 

  10. Machaca M, Bodean ML, Montaña S, García SD, Stecher D, Vay CA, et al. Description of a case of abdominal sepsis due to Desulfovibrio desulfuricans. Rev Argent Microbiol. 2022;54:314–7.

    PubMed  Google Scholar 

  11. Marquis TJ, Williams VJ, Banach DB. Septic arthritis caused by Desulfovibrio desulfuricans: a case report and review of the literature. Anaerobe. 2021;70:102407.

    Article  PubMed  Google Scholar 

  12. Tanamachi C, Hashimoto K, Itoyama T, Horita R, Yano T, Tou K, et al. A case of Desulfovibrio desulfuricans cultured from blood in Japan. Rinsho Byori. 2011;59:466–9.

    PubMed  Google Scholar 

  13. Verstreken I, Laleman W, Wauters G, Verhaegen J. Desulfovibrio desulfuricans bacteremia in an immunocompromised host with a liver graft and ulcerative colitis. J Clin Microbiol. 2012;50:1.

    Article  Google Scholar 

  14. Otto MP, Berend M, Thibault F, Wey PF, Gérôme P. Desulfovibrio desulfuricans bacteremia. Med Mal Infect. 2014;44:233–5.

    Article  PubMed  Google Scholar 

  15. Fernández Vecilla D, Roche Matheus MP, Calvo Muro FE, Iglesias Hidalgo G, Díaz de Tuesta Del Arco JL. Identification of curved gram-negative rods by MALDI-TOF mass spectrometer in a patient with Fournier ́s gangrene. A bacteremia caused by Desulfovibrio desulfuricans and Escherichia coli. Rev Esp Quimioter. 2023;36:629–31.

    Article  PubMed  Google Scholar 

  16. Predari SC, de Paulis AN, Bertona E, Núñez DG, Suárez JP, Castello L. Anaerobiospirillum succiniciproducens and Desulfovibrio desulfuricans in 2 cases of insidious bacteremia. Rev Argent Microbiol. 2017;49:146–52.

    PubMed  Google Scholar 

  17. Yamazaki T, Joshita S, Kasuga E, Horiuchi K, Sugiura A, Fujimori N, et al. A case of liver abscess co-infected with Desulfovibrio desulfuricans and Escherichia coli and review of the literature. J Infect Chemother. 2018;24:393–7.

    Article  PubMed  Google Scholar 

  18. Koyano S, Tatsuno K, Okazaki M, Ohkusu K, Sasaki T, Saito R, et al. A case of liver abscess with Desulfovibrio desulfuricans bacteremia. Case Rep Infect Dis. 2015;2015:354168.

    PubMed  PubMed Central  Google Scholar 

  19. Fujihara T, Kimura K, Matsuo H, Sada RM, Hamaguchi S, Yamamoto G, et al. Aneurysm infection caused by Desulfovibrio desulfuricans. Emerg Infect Dis. 2023;29:1680–1.

    Article  PubMed  PubMed Central  Google Scholar 

  20. Liderot K, Larsson M, Boräng S, Ozenci V. Polymicrobial bloodstream infection with Eggerthella lenta and Desulfovibrio desulfuricans. J Clin Microbiol. 2010;48:3810–2.

    Article  PubMed  PubMed Central  Google Scholar 

  21. Hagiwara S, Yoshida A, Omata Y, Tsukada Y, Takahashi H, Kamewada H, et al. Desulfovibrio desulfuricans bacteremia in a patient hospitalized with acute cerebral infarction: a case report and review. J Infect Chemother. 2014;20:274–7.

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

Not applicable.

Funding

Not applicable.

Author information

Authors and Affiliations

Authors

Contributions

KY managed the case and prepared and revised the manuscript. MK assisted with the preparation and revision of the manuscript. MK and TK assisted with data analysis and revision of the manuscript. All co-authors approve the final manuscript as submitted and agree to be accountable for all aspects of the work. All co-authors take full responsibility for the integrity of the report and the final manuscript.

Corresponding author

Correspondence to Tsuneaki Kenzaka.

Ethics declarations

Ethics approval and consent to participate

The Hyogo Prefectural Tamba Medical Center ethics committee waived the requirement for ethical approval and consent due to the study’s retrospective nature. This study was carried out in accordance with the guidelines of the Declaration of Helsinki.

Consent for publication

Written informed consent was obtained from the patients to publish this case report and accompanying images. A copy of the written consent is available for review by the editor of this journal.

Competing interests

The authors declare no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Yamaizumi, K., Kyotani, M. & Kenzaka, T. Bacteremia caused by Desulfovibrio desulfuricans with the intestinal tract as the portal of entry: two case reports and a literature review. BMC Infect Dis 24, 725 (2024). https://doi.org/10.1186/s12879-024-09623-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s12879-024-09623-3

Keywords